SIGMI Trademark
SIGMI is a USPTO trademark filed by Direct Biologics LLC. Status: Pending.
Trademark Facts
| Mark | SIGMI |
|---|---|
| Serial Number | 98359126 |
| Status | Pending |
| Filing Date | 2024-01-16 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Direct Biologics LLC |
| Attorney of Record | Aaron D. Hendelman |
| Prosecution Events | 27 |
| Latest Event | EX3G on 2026-05-08 |
Goods & Services
Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.